A microfluidic chip developed at the University of Michigan is among the best at capturing elusive circulating tumor cells from blood—and it can support the cells’ growth for further analysis.
The device, believed to be the first to pair these functions, uses the advanced electronics material graphene oxide. In clinics, such a device could one day help doctors diagnose cancers, give more accurate prognoses and test treatment options on cultured cells without subjecting patients to traditional biopsies.
“If we can get these technologies to work, it will advance new cancer drugs and revolutionize the treatment of cancer patients,” said Max Wicha, M.D., Distinguished Professor of Oncology and director of the U-M Comprehensive Cancer Center and co-author of a paper on the new device, published online this week in Nature Nanotechnology.
“Circulating tumor cells will play a significant role in the early diagnosis of cancer and to help us understand if treatments are working in our cancer patients by serving as a ‘liquid’ biopsy to assess treatment responses in real time,” said co-author Dr. Diane Simeone, the Lazar J. Greenfield Professor of Surgery at the U-M Medical School and director of the Translational Oncology Program.
“Studies of circulating tumor cells will also help us understand the basic biologic mechanisms by which cancer cells metastasize or spread to distant organs—the major cause of death in cancer patients.”
Yet these cells aren’t living up to their promise in medicine because they are so difficult to separate from a blood sample, the researchers say. In the blood of early-stage cancer patients, they account for less than one in every billion cells, so catching them is tougher than finding the proverbial needle in a haystack.
“I can burn the haystack or use a huge magnet,” said Sunitha Nagrath, an assistant professor of chemical engineering, who led the research. “When it comes to circulating tumor cells, they almost look like—feel like—any other blood cell.”
On their microfluidic chip, Nagrath’s team grew dense forests of molecular chains, each equipped with an antibody to grab onto cancer cells.
Even after the cells are caught, it’s still hard to run a robust analysis on just a handful of them, the researchers say. That’s why this demonstration of highly sensitive tumor cell capture, combined with the ability to grow the cells in the same device, is so promising.
Hyeun Joong Yoon, a postdoctoral researcher in the Nagrath lab with a background in electrical engineering, was instrumental in making the microfluidic chip. He started with a silicon base and added a grid of nearly 60,000 flat gold shapes, like four-petaled flowers, each no wider than a strand of hair.
The gold flowers naturally attracted a relatively new material called graphene oxide. These sheets of carbon and oxygen, just a few atoms thick, layered themselves over the gold. This layered formation allowed the team to grow the tumor-cell-catching molecular chains so densely.
“It’s almost like each graphene has many nano-arms to capture cells,” Nagrath said.
To test the device, the team ran one-milliliter samples of blood through the chip’s thin chamber. Even when they had added just three-to-five cancer cells to the 5-10 billion blood cells, the chip was able to capture all of the cells in the sample half the time, with an average of 73 percent over 10 trials.
“That’s the highest anybody has shown in the literature for spiking such a low number of cells,” Nagrath said.
The Latest Bing News on:
Liquid biopsy
- New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomeson April 17, 2024 at 5:35 am
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the Company has ...
- JCO Precision Oncology Conversationson April 16, 2024 at 5:01 pm
Dr. Christian Rolfo: Thank you very much, Rafeh. It's a pleasure to be here and discuss about liquid biopsy. Dr. Rafeh Naqash: You have a very important role in different liquid biopsy consortiums.
- Non-Invasive Liquid Biopsy Market CAGR of 15.7%, Size, Trends, Growth Status, Share, Research, and Forecast 2024 to 2032on April 16, 2024 at 2:06 pm
Liquid biopsy has emerged as a promising non-invasive technique for detecting and monitoring various types of cancers. Unlike traditional tissue biopsies, which often involve invasive procedures, ...
- Liquid Biopsy Whole-Genome Sequencing Optimizes MRD Detection in DLBCLon April 13, 2024 at 5:00 am
Using the newly created MAESTRO-Pool tool, whole genome sequencing revealed DNA that could be used to more effectively detect minimum residual disease (MRD) in patients who have diffuse large B-cell ...
- Ovarian Cancer: Another Promising Target for Liquid Biopsyon April 11, 2024 at 5:00 pm
He called liquid biopsy "a great advance" in many oncology settings, including cancer screening because finding tumors early offers the best chance at cure. However, one of the main concerns about ...
- Liquid Biopsy Has Near-Perfect Accuracy for Early Pancreatic Canceron April 10, 2024 at 6:24 am
A new screening test raises the possibility of catching pancreatic cancer earlier, when tumors can be removed, and patients cured.
- An exosome-based liquid biopsy shows promise for early detection of pancreatic canceron April 8, 2024 at 12:00 pm
An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American ...
- There’s still no standard test to detect pancreatic cancer early. Scientists are working to change thaton April 8, 2024 at 8:31 am
Across the United States, research teams are investigating ways to spot early cases, with many turning to blood-based liquid biopsy tests. “This term ‘liquid biopsy,’ essentially ...
- New liquid biopsy screening test for pancreatic cancer shows promise in early dataon April 8, 2024 at 8:31 am
Early data on a new blood test, which looks for bits of RNA discharged by tumors, suggests it might be able to detect pancreatic cancer at stage 1 or 2 with a sensitivity of over 90%.
- There’s still no standard test to detect pancreatic cancer early. Scientists are working to change thaton April 8, 2024 at 8:31 am
To spot breast cancer early, there are mammograms. To find colon cancer early, there are colonoscopies. But there is no standard recommended test to detect early cases of pancreatic cancer – when the ...
The Latest Google Headlines on:
Liquid biopsy
[google_news title=”” keyword=”Liquid biopsy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Diagnosing cancers
- King Charles' Cancer Is 'Going in the Right Direction' Despite Prince William 'Feeling the Strain' of His Diagnosison April 19, 2024 at 1:31 pm
King Charles is currently undergoing cancer treatment, and His Majesty is prioritizing his health as Prince William becomes the forward-facing leader of The Crown. Although Charles has been private ...
- I’ve always loved relics. After my cancer diagnosis, they mean even more to me.on April 19, 2024 at 10:56 am
Our theology of relics tells us something beautiful and profound not only about God but about what we believe about materiality itself.
- 'Shopaholic' author Sophie Kinsella sends message to fans after revealing brain cancer diagnosison April 19, 2024 at 10:32 am
Sophie Kinsella, 54, shared on social media that she has glioblastoma. The author of the "Shopaholic" book series that was turned into a hit movie is sending a message to fans after revealing she is ...
- Canadian influencer Sarah DeMelo says 'cancer really does change your life' as she marks 1 year since diagnosison April 19, 2024 at 10:10 am
Canadian influencer Sarah DeMelo reflected on a milestone in her battle against cancer. Earlier this week, the Oakville, Ont. content creator took to social media to commemorate one year since doctors ...
- What to know about prostate cancer following Francis Collins’ diagnosison April 19, 2024 at 3:00 am
When Francis S. Collins first learned that his prostate-specific antigen levels were rising, he wasn’t particularly worried. A slow rise in PSA levels, which can indicate the presence of prostate ...
- Prince William shares promise about Kate Middleton amid cancer diagnosison April 18, 2024 at 9:40 pm
Prince William continued to honor his wife Kate Middleton during his first public service engagement since the Princess of Wales announced her cancer diagnosis.
- Dickey Betts Died, ‘Shopaholic’ Author Announces Cancer Diagnosis and Moreon April 18, 2024 at 5:00 pm
From the Allman Brothers Band’s singer Dickey Betts dying after a cancer diagnosis to the “Shopaholic” author announcing her glioblastoma diagnosis, here’s what is happening in the cancer space this ...
- ‘Unabomber’ Ted Kaczynski diagnosed with cancer one month before killing himself in prison last year, autopsy revealson April 18, 2024 at 10:33 am
Ted Kaczynski, otherwise known as the Unabomber, had been diagnosed with rectal cancer in 2021, just two years before he died by suicide in prison, according to a new report. Kaczynski was 81 when he ...
- Prince William returns to royal duty nearly 1 month after Kate Middleton's cancer diagnosis announcementon April 18, 2024 at 8:20 am
On Thursday, the Prince of Whales visited a food redistribution charity called Surplus to Supper. It is his first official royal outing since Kate Middleton revealed her cancer diagnosis.
- 'Shopaholic' author Sophie Kinsella diagnosed with 'aggressive' brain canceron April 18, 2024 at 6:33 am
Sophie Kinsella, author of the "Shopaholic" book series, has revealed she is battling an "aggressive" form of brain cancer.
The Latest Google Headlines on:
Diagnosing cancers
[google_news title=”” keyword=”diagnosing cancers” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]